Evidence map›Paper›PMID 41004486›Full record

ArticlePloS one2025

Gene electrotransfer with flow-through microchannel and lower alternating voltage generated induced pluripotent cells from human lymphoblastoid cell lines.

Miho Ishii-Teshima, Koki Maeda, Kazuki Hanauchi, Emika Asechi, Defan Setyawan, Takeshi Niki, Kenji Nakashima, Hirofumi Kurita, Rika Numano, Takayuki Shibata

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Miho Ishii-TeshimaDepartment of Mechanical Engineering, Toyohashi University of Technology, Toyohashi, Japan.ORCID 0009-0006-5214-4315
Koki MaedaDepartment of Mechanical Engineering, Toyohashi University of Technology, Toyohashi, Japan.
Kazuki HanauchiDepartment of Applied Chemistry and Life Science, Toyohashi University of Technology, Toyohashi, Japan.
Emika AsechiNational Institute of Technology (Kosen), Sasebo College, Sasebo, Nagasaki, Japan.
Defan SetyawanDepartment of Mechanical Engineering, Toyohashi University of Technology, Toyohashi, Japan.
Takeshi NikiDepartment of Applied Chemistry and Life Science, Toyohashi University of Technology, Toyohashi, Japan.
Kenji NakashimaNational Institute of Technology (Kosen), Sasebo College, Sasebo, Nagasaki, Japan.
Hirofumi KuritaDepartment of Applied Chemistry and Life Science, Toyohashi University of Technology, Toyohashi, Japan.ORCID 0000-0002-2538-6590
Rika NumanoDepartment of Applied Chemistry and Life Science, Toyohashi University of Technology, Toyohashi, Japan.
Takayuki ShibataDepartment of Mechanical Engineering, Toyohashi University of Technology, Toyohashi, Japan.

Funding

Grants-in-Aid for Scientific ResearchJSPS KAKENHI 22J40077JSPS KAKENHI - Japan Society for the Promotion of ScienceThe Hibi Science FoundationThe Naito Reserch Grant from the Naito Science & Engineering Foundation
6 · The paper itself

Abstract

Induced pluripotent stem cells (iPSCs) are useful for studying genetic and rare diseases and can be generated by reprogramming immortalized lymphoblastoid cell lines (LCLs) stored in global repositories with detailed genotype and phenotype data. Traditional bulk-type electroporators are commonly used for gene electrotransfer in reprogramming, but they have major drawbacks, including high costs associated with electric pulse generators and the requirement for fixed volumes for costly reprogramming factors. These limitations hinder cost-effective and scalable iPSC generation, particularly when working with large numbers of LCLs with diverse genotypes. We aimed to develop a flow-through-type electroporator utilizing microchannels for the generation of iPSCs from LCLs, to reduce the costs associated with traditional bulk-type electroporators and enable parallel processing for LCLs with various genotypes. We applied a continuous wave of biphasic alternating voltage (~10 V one-sided amplitude) to micro-scaled electrodes within the microchannel to develop a flow-through electroporator. Numerical simulations were conducted to assess the electric field distribution and its applicability to pore formation in the plasma membrane. To optimize electroporation and flow conditions, we used plasmid pCXLE-EGFP (encoding Green Fluorescent Protein, GFP) for gene electrotransfer to LCLs. Reprogramming factors (pCXLE-hSK, pCXLE-hOCT3/4-shp53-F, pCXLE-hUL) were also delivered to the cells via the same system. The flow-through electroporator achieved 31% transfection efficiency with 78% cell viability, 2 d post-electroporation. In each condition, only 3 µL of cell suspension was used with 107 cells/mL of cells and 500 ng/µL plasmid vector. A reprogramming efficiency of 0.048% was obtained, which is comparable to that achieved using bulk-type electroporators. This developed flow-through electroporator with microchannel technology offers significant advantages over traditional methods, including the potential to reduce costs and the ability to process small volumes of cell suspension, making it suitable for parallel processing of LCLs with diverse genotypes. The system provides a promising approach for scalable and potentially cost-effective iPSC generation.

Indexed as

ElectroporationGene Transfer TechniquesInduced Pluripotent Stem CellsLymphocytesCell LineCellular ReprogrammingHumans

Identifiers

PMID41004486
PMCPMC12468887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.